Navigation Links
Ampio Pharmaceuticals Announces Participation at Upcoming Investor Conference
Date:1/22/2013

mmatory compounds by affecting specific pathways at the protein expression and at the transcription level or 2) activation of a specific phosphatase or depletion of the available phosphate needed for the inflammation process. For more information visit: www.ampiopharma.com.

About Noble Financial

Noble Financial Capital Markets was established in 1984 and is an equity research driven, full-service, investment banking boutique focused on life sciences, technology and media, emerging growth, companies. The company has offices in New York, Boston, New Jersey, Los Angeles, and Boca Raton, FL. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in January in South Florida featuring 120-150 presenting companies from across North America and total attendance of close to 600. For more information: www.noblefcm.com

Forward Looking Statement

Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include risks associated with clinical trials, expected results, regulatory approvals, successful commercialization and marketing of Zertane™ and the combination drug in Korea, and changes in business conditions and similar events. The risks and uncertainties involved include those detailed from time to time in Ampio's filings with the Securities and Exchange Commissio
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
2. Four Californians Selected As Breakaway from Cancer® Champions To Be Honored During Amgen Tour of California
3. Ampio Pharmaceuticals Schedules 2012 Update Webcast
4. Four-Time Triathlon World Champion Melanie McQuaid Selects Polar USA as Official Heart Rate Training Solution
5. Ampios CEO and CSO Send Message to Shareholders
6. Ampio Pharmaceuticals Announces Proposed Public Offering
7. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
8. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
9. Ampio Advances NCE001 Cancer Drug into Preclinical Development Following Successful Recent Financing and the Granting of Patents in USA, Canada, Europe and China
10. Ampio Pharmaceuticals Announces Closing of Public Offering
11. eCardio Supports the Carolinas HealthCare Foundation Through Grant for Heart Of A Champion Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Nov. 25, 2014  Medtronic,s roughly $43 ... been widely discussed in the media for its ... a stronger leading player in one of the ... The healthcare market research firm said  the two ... a diverse set of solutions spanning inpatient to ...
(Date:11/26/2014)... , Nov. 25, 2014  Array ... today announced that its Chief Executive Officer, ... the following upcoming conferences.  The public is ... webcasts on the Array BioPharma website:  ... 3, 2014Time:1:30 p.m.  Eastern Time Location: Palace ...
(Date:11/26/2014)... PITUACH, Israel, Nov. 25, 2014 Immune Pharmaceuticals ... clinical stage biopharmaceutical company that engages in the ... treatment of inflammatory diseases and cancer, today announced ... offering of 3,450,000 units, with each unit consisting ... par value $0.0001 per share, and one warrant ...
Breaking Medicine Technology:Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5
... Exceptionally high costs.  Long research and development cycles.  Low ...  Dependence on out-dated information technology options.  It,s not just ... information being wasted.   Such ... have led to the formation of a new company, ...
... -- XIANYANG, China, Aug. 17 /PRNewswire-Asia-FirstCall/ -- ... ... var ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
Cached Medicine Technology:RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 2RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 3RedOak Logic's Mission: Transform Pharmaceutical Industry Drug Development 4Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 2Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 3Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 4Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 5Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 6Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 7Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 8Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 9Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 10Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 11Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 12Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 13Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 14Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million 15
(Date:11/27/2014)... 2014 “Wekho” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers ... , An interesting new way to travel and experience the ... It’s called Wekho and it’s a free geolocation app ...
(Date:11/27/2014)... This is a professional and in ... an overview analysis, the report introduces Insulin basic ... industry overview, policy analysis, and news analysis, etc. ... information on policy, plans for Insulin Market product ... more. , This report also provides ...
(Date:11/27/2014)... 2014 At The Little Gym, we ... came as no surprise when a recent study confirmed ... success. The Journal of Pediatrics found that ... tasks during the school years may be important not ... The study monitored two groups of children; those that ...
(Date:11/27/2014)... 2014 The Emerald Cup 2014 Competition ... At This Year’s Entries | SKUNK Magazine – Proudly ... Two At Their Resort, Pure Garden, In Negril, Jamaica ... Hempcon, The Emerald Cup is presented by locals, for ... of California’s original cannabis industry." – SFGate, Smell The ...
(Date:11/27/2014)... November 27, 2014 In addition to ... an important gift home this holiday season and become ... disease. Visiting with relatives over the holidays may raise ... members. Although some change in cognitive ability can occur ... of normal aging. Recognizing the difference between normal aging ...
Breaking Medicine News(10 mins):Health News:A New Geolocation Mobile Application and was Featured on NewsWatch Television on October 30, 2014 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 2Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 3Health News:The Emerald Cup 2014 Competition Partners | CannCast – Bringing You An Up-Close Look At This Year’s Entries and SKUNK Magazine Proudly Sponsoring This Year's Grand Prize 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 2Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 3Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 4Health News:Alzheimer's Association Shares Tips to Navigate the Holiday Season 5
... Athens, Ga. - Pharmaceutical companies and universities are racing to ... RNA interference to treat a host of diseases. Now, a ... powerful tool: Researchers at the University of Georgia have demonstrated ... as a tool in the development of vaccines. , ...
... Dec. 10 /PRNewswire/ - Over 830 staff members are ... District,s newest fitness challenge. The 322 mile virtual race ... online challenge and it,s proving successful with less work ... Lee County School District has delivered fitness ...
... A University of British Columbia geneticist has discovered a gene ... uveal melanoma. , Catherine Van Raamsdonk, an assistant professor of ... team of researchers, have discovered a genetic mutation in a ... cent of the cases of uveal melanoma. , The findings, ...
... survey cites misperceptions regarding need for vaccination and a lack of ... , ... Bethesda, MD (PRWEB) December 10, 2008 -- A ... one-third (29.6 percent) have been vaccinated against the flu this season. ...
... superior to vitamin supplementation for cancer prevention. , ... ... of announcements two weeks ago that vitamin supplements A thru E ... more medical announcements with the same conclusions regarding prostate cancer. While ...
... 10 Markel Corporation is,pleased to announce the launch ... product. DataBreach(SM) helps businesses manage,risk associated with their reliance ... in their custody or care. , ... the increase in identity theft,that has been plaguing businesses ...
Cached Medicine News:Health News:Study first to show that RNA interference can facilitate vaccine development 2Health News:Study first to show that RNA interference can facilitate vaccine development 3Health News:Lee County School District online wellness program inspires employees to walk 200 million steps in 2 months 2Health News:UBC researchers discover gene mutation that causes eye cancer 2Health News:Mid-Season Flu Immunization Rates are Too Low 2Health News:Mid-Season Flu Immunization Rates are Too Low 3Health News:Mid-Season Flu Immunization Rates are Too Low 4Health News:Mid-Season Flu Immunization Rates are Too Low 5Health News:Treadmill Desks More Effective in Decreasing Prostate Cancer Risks Than Vitamin and Antioxidant Supplements 2Health News:Markel Corporation Announces New DataBreach(SM) Privacy Liability Coverage 2
... For treatment of carpal tunnel syndrome, mild ... following cast removal. The perforated suede ... the wrist, wicking away moisture for long ... metal splint prevents painful wrist flexion, and ...
... orthotic elbow system that can be used in ... proximal ulnar fractures or post reconstructive surgery where ... highly flexible system that provides you with a ... that best fits your patients needs. Two ...
A lightweight soft good with rigid elbow protection. Designed by medical professionals with your needs in mind. Provides elbow stability for mild to moderate medial/lateral and hyperextension injurie...
Worn by many professional athletes, EpiTrain is our most popular elbow support....
Medicine Products: